Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2011

01-08-2011 | Case Report

A case of a 6-year-old girl with anti-neutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis

Authors: Maki Shimizu, Takanori Sekiguchi, Natsuko Kishi, Aya Goji, Tomoko Takahashi, Hiroko Kozan, Zenichi Sakaguchi, Yukiko Kinoshita, Sato Matsuura, Kenichi Suga, Maki Urushihara, Shuji Kondo, Shoji Kagami, Katsuaki Ohara

Published in: Clinical and Experimental Nephrology | Issue 4/2011

Login to get access

Abstract

A 6-year-old girl was admitted to our hospital with proteinuria, hematuria, skin rash and joint pain of the lower limbs. Due to rapid progression of renal insufficiency, hemodialysis and peritoneal dialysis were performed. She was diagnosed with rapidly progressive glomerulonephritis. Kidney biopsy showed severe crescent formation (50% of glomeruli) and no deposition of any immunoglobulins or complements. Serologically, anti-neutrophil cytoplasmic autoantibody (ANCA) was negative not only by ELISA against proteinase-3 and myeloperoxidase-ANCA but also by indirect immunofluorescent assay against cytoplasmic and perinuclear ANCA. Anti-glomerular basement membrane antibody was also negative. In the acute phase, proinflammatory cytokines such as soluble tumor necrosis factor receptor 1 (sTNFR1), soluble interleukin (IL)-2 receptor (sIL2R), IL-6 and chemokine IL-8 were elevated. The patient was diagnosed with ANCA-negative pauci-immune crescentic glomerulonephritis (CrGN). Intensive treatment with methylprednisolone pulse therapy, plasma exchange, and multiple drug therapy including prednisolone and cyclophosphamide resulted in histopathological improvement and complete remission of proteinuria. There was a possibility that sTNFR1, sIL2R, IL-6 and IL-8 might be involved in the initiation and progression of ANCA-negative pauci-immune CrGN, and to remove and suppress these cytokines might be an effective way to treat ANCA-negative pauci-immune CrGN.
Literature
1.
go back to reference Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenic mechanisms, and therapy. Am J Kidney Dis. 1998;6:449–64. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenic mechanisms, and therapy. Am J Kidney Dis. 1998;6:449–64.
2.
go back to reference Bolton WK. Rapidly progressive glomerulonephritis. Semin Nephrol. 1996;6:517–26. Bolton WK. Rapidly progressive glomerulonephritis. Semin Nephrol. 1996;6:517–26.
3.
go back to reference Morgan MD, Harper L, Williams J, Savage C. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol. 2006;17:1224–34.CrossRefPubMed Morgan MD, Harper L, Williams J, Savage C. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol. 2006;17:1224–34.CrossRefPubMed
4.
go back to reference Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY. Antineutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol. 2007;18:599–605.CrossRefPubMed Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY. Antineutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol. 2007;18:599–605.CrossRefPubMed
5.
go back to reference Hung PH, Chiu YL, Lin WC, Chiang WC, Chen YM, Lin SL, et al. Poor renal outcome of antineutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc. 2006;10:804–12.CrossRef Hung PH, Chiu YL, Lin WC, Chiang WC, Chen YM, Lin SL, et al. Poor renal outcome of antineutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc. 2006;10:804–12.CrossRef
6.
go back to reference Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, et al. ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant. 2005;20:1392–9.CrossRefPubMed Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, et al. ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant. 2005;20:1392–9.CrossRefPubMed
7.
go back to reference Harada T, Uzu T, Namba T, Yamamoto R, Takahara K, Yamauchi A. ANCA-negative pauci-immune crescentic glomerulonephritis complicated with recurrent massive gastrointestinal hemorrhage. Clin Exp Nephrol. 2005;9:174–8.CrossRefPubMed Harada T, Uzu T, Namba T, Yamamoto R, Takahara K, Yamauchi A. ANCA-negative pauci-immune crescentic glomerulonephritis complicated with recurrent massive gastrointestinal hemorrhage. Clin Exp Nephrol. 2005;9:174–8.CrossRefPubMed
8.
go back to reference Chow KM, Wang AY, Mac-Moune Lai F, Wong TY, Li PK. Rapid recurrence of ANCA-negative pauci-immune vasculitis after cadaveric renal transplantation. Am J Kidney Dis. 2001;1:E3. Chow KM, Wang AY, Mac-Moune Lai F, Wong TY, Li PK. Rapid recurrence of ANCA-negative pauci-immune vasculitis after cadaveric renal transplantation. Am J Kidney Dis. 2001;1:E3.
9.
go back to reference Fukuda Y, Watanabe H, Ohtomo Y, Yabuta K. Immunologically mediated chronic tubulo-interstitial nephritis caused by valproate therapy. Nephron. 1996;72:328–9.CrossRefPubMed Fukuda Y, Watanabe H, Ohtomo Y, Yabuta K. Immunologically mediated chronic tubulo-interstitial nephritis caused by valproate therapy. Nephron. 1996;72:328–9.CrossRefPubMed
10.
go back to reference Ackoundou-N’guessan C, Canaud B, Leray-Moragues H, Droz D, Baldet P, Pages M. Collapsing focal segmental glomerulosclerosis as a possible complication of valproic acid. S Afr Med J. 2007;97:388–90.PubMed Ackoundou-N’guessan C, Canaud B, Leray-Moragues H, Droz D, Baldet P, Pages M. Collapsing focal segmental glomerulosclerosis as a possible complication of valproic acid. S Afr Med J. 2007;97:388–90.PubMed
11.
go back to reference Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA. 1990;87:4115–9.CrossRefPubMed Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA. 1990;87:4115–9.CrossRefPubMed
12.
go back to reference Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Nakabayashi K, Kitamoto K, et al. Serum myeloperoxidase and serum cytokine in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol. 1993;5:256–64. Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Nakabayashi K, Kitamoto K, et al. Serum myeloperoxidase and serum cytokine in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol. 1993;5:256–64.
13.
go back to reference Condliffe AM, Chilvers ER, Haslett C, Dransfield I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology. 1996;89:105–11.CrossRefPubMedPubMedCentral Condliffe AM, Chilvers ER, Haslett C, Dransfield I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology. 1996;89:105–11.CrossRefPubMedPubMedCentral
14.
go back to reference Matsumoto K. Spontaneous release of interleukin-8 by glomerular macrophages from patients with rapidly progressive crescentic glomerulonephritis. Nephrol Dial Transplant. 1994;9:1693.PubMed Matsumoto K. Spontaneous release of interleukin-8 by glomerular macrophages from patients with rapidly progressive crescentic glomerulonephritis. Nephrol Dial Transplant. 1994;9:1693.PubMed
15.
16.
go back to reference Zhou Z, Richard C, Menard HA. De novo synthesis of proteinase 3 by cytokine primed circulating human polymorphonuclear neutrophils and mononuclear cells. J Rheumatol. 2000;10:2406–11. Zhou Z, Richard C, Menard HA. De novo synthesis of proteinase 3 by cytokine primed circulating human polymorphonuclear neutrophils and mononuclear cells. J Rheumatol. 2000;10:2406–11.
17.
go back to reference Cockwell P, Brooks CJ, Adu D, Savage C. Interleukin-8: a pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int. 1999;55:852–63.CrossRefPubMed Cockwell P, Brooks CJ, Adu D, Savage C. Interleukin-8: a pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int. 1999;55:852–63.CrossRefPubMed
Metadata
Title
A case of a 6-year-old girl with anti-neutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis
Authors
Maki Shimizu
Takanori Sekiguchi
Natsuko Kishi
Aya Goji
Tomoko Takahashi
Hiroko Kozan
Zenichi Sakaguchi
Yukiko Kinoshita
Sato Matsuura
Kenichi Suga
Maki Urushihara
Shuji Kondo
Shoji Kagami
Katsuaki Ohara
Publication date
01-08-2011
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0423-3

Other articles of this Issue 4/2011

Clinical and Experimental Nephrology 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.